Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Marjolaine Gauthier‐Loiselle
ResearcherPublications, citations & collaboration network
Marjolaine Gauthier‐Loiselle is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 118 works, 2,140 citations, an h-index of 19 and an i10-index of 32.
118
Works
2,140
Citations
19
h-index
32
i10-index
How has Marjolaine Gauthier‐Loiselle's publication output changed over time?
ScholarIQpublication output · 2008–2021
Output grew0% over the shown period — from 1 works in 2008 to 1 in 2021.
1
1
1
5
1
1
1
2008200920102018201920202021
What are the most-cited papers on Marjolaine Gauthier‐Loiselle?
ScholarIQmost cited works
How Much Does Immigration Boost Innovation?
Jennifer Hunt, Marjolaine Gauthier‐Loiselle
S170166683. 2010816 CitationsOPEN ACCESS
How Much Does Immigration Boost Innovation?
Jennifer Hunt, Marjolaine Gauthier‐Loiselle
SSRN Electronic Journal. 2009201 CitationsOPEN ACCESS
Assessment of costs associated with adverse events in patients with cancer
William B. Wong, Yeun Mi Yim, Ashley Kim, Martin Cloutier, Marjolaine Gauthier‐Loiselle, Patrick Gagnon‐Sanschagrin, Annie Guérin
PLoS ONE. 2018171 CitationsOPEN ACCESS
How Much Does Immigration Boost Innovation?
Jennifer Hunt, Marjolaine Gauthier‐Loiselle
S2809516038. 200879 CitationsOPEN ACCESS
The risk of cardiovascular events in psoriasis patients treated with tumor necrosis factor–α inhibitors versus phototherapy: An observational cohort study
Jashin J. Wu, Murali Sundaram, Martin Cloutier, Marjolaine Gauthier‐Loiselle, Annie Guérin, Rakesh Singh, Arijit Ganguli
S58727509. 201867 Citations
Related on ScholarIQ
Group for Research in Decision Analysis
Institution
How Much Does Immigration Boost Innovation?
Paper
How Much Does Immigration Boost Innovation?
Paper
Assessment of costs associated with adverse events in patients with cancer
Paper
How Much Does Immigration Boost Innovation?
Paper
The risk of cardiovascular events in psoriasis patients treated with tumor necrosis factor–α inhibitors versus phototherapy: An observational cohort study
Paper